Morphine and naloxone, IP or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 809-816

  Rada, Pedro V ^a,b   Mark, Gregory P ^a,c   Taylor, Kathleen M ^a   Hoebel, Hartley G ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Addiction; Methylnaloxonium; Microdialysis; Morphine; Nucleus accumbens; Opiates; Prefrontal cortex; Rats; Withdrawal

Indexed keywords

17 METHYLNALOXONE; ACETYLCHOLINE; MORPHINE; NALOXONE; DRUG DERIVATIVE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; QUATERNARY AMMONIUM DERIVATIVE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICRODIALYSIS; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REWARD; WITHDRAWAL SYNDROME; ANIMAL; DRUG EFFECT; INJECTION; METABOLISM; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT;

ANIMALIA;

ACETYLCHOLINE; ANIMALS; INJECTIONS; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029665572     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02078-0     Document Type: Article

References (52)

1. Abdelhamid, E. E.; Takemori, A. E. Characteristics of mu and delta binding sites in striatal slices of morphine-tolerant and -dependent mice. Eur. J. Pharmacol. 198:157-163; 1991.
2. Antonelli, T.; Beani, L.; Bianchi, C.; Rando, S.; Simonato, M.; Tanganelli, S. Cortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawal. Br. J. Pharmacol. 89:853-860; 1986.
3. + or glutamic acid from rat neostriatal slices. Brain Res. 523:51-56; 1990.
4. Bartoletti, M.; Gaiardi, M.; Gubellini, G.; Bacchi, A.; Babbini, M. Long-term sensitization to the excitatory effects of morphine. Neuropharmacology 22:1193-1196; 1983.
5. Bartoletti, M.; Gaiardi, M.; Gubellini, C.; Bachi, A.; Babbini, M. Effects of buprenorphine on motility in chronically morphine treated rats. Neuropharmacology 32:865-868; 1993.
6. Beani, L.; Bianchi, C.; Siniscalchi, A. The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices. Br. J. Pharmacol. 76:393-401; 1982.
7. Bhargava, H. N.; Way, E. L. Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. J. Pharmacol. Exp. Ther. 183:31-40; 1972.
8. Bhargava, H. N.; Way, E. L. Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal. J. Pharmacol. Exp. Ther. 194:65-73; 1975.
9. Brog, J. S.; Salyapongse, A.; Deutch, A. Y.; Zahm, D. S. The patterns of afferent innervation of the core and shell in the accumbens part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338:255-278; 1993.
10. Buccafusco, J. J. Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP). Life Sci. 48: 749-756; 1991.
11. Cheney, D. L.; Trabucchi, M.; Racagni, G.; Wang, C.; Costa, E. Effects of acute and chronic morphine on regional rat brain acetylcholine turnover rate. Life Sci. 15:1977-1990; 1974.
12. Costa, E.; Cheney, D. L.; Racagni, G.; Zsilla, G. An analysis at synaptic level of the morphine action in striatum and n. accumbens: Dopamine and acetylcholine interactions. Life Sci. 17:1-8; 1975.
13. Crossland, J.; Ahmed, K. Z. Brain acetylcholine during morphine withdrawal. Neurochem. Res. 9:351-366; 1984.
14. Davis, M.; Smith, S. Central cholinergic influence on self-administration of morphine and amphetamine. Life Sci. 16:237-246; 1975.
15. De Vries, T. J.; Tjon Tien Ril, G. H. K.; Van der Laan, J. W.; Mulder, A. H.; Schoffelmeer, A. N. M. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity. Life Sci. 52:1685-1693; 1993.
16. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278; 1988.
17. Ennis, C.; Wyllie, M. G. Evidence for functionally distinct μ receptors modulating acetylcholine release. Neuropeptides 5:109-112; 1984.
18. 14C]-acetylcholine release from rat nucleus accumbens slices. Naunyn-Schmied. Arch. Pharmacol. 345:627-632; 1992.
19. Hernandez, L.; Hoebel, B. G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42:705-712; 1988.
20. Hernandez, L.; Stanley, B. G.; Hoebel, B. G. A small, removable microdialysis probe. Life Sci. 39:2629-2637; 1986.
21. Hoebel, B. G.; Hernandez, L.; Mark, G. P.; Pothos, E. Microdialysis in the study of psychostimulants and the neural substrate for reinforcement: Focus on dopamine and serotonin. In: Frascella, J.; Brown, R., eds. Neurobiological approaches to brain-behavior interaction. Washington, DC: National Institute of Drug Abuse; 1992:124:1-34.
22. Hoebel, B. G.; Rada, P.; Mark, G. P.; Hernandez, L. The power of integrative peptides to reinforce behavior by releasing dopamine. In: Strand, F. L.; Beckwith, B.; Chronwall, B.; Sandman, C. A., eds. Models of neuropeptide action. New York: Annals of the New York Academy of Sciences; 1994:739:36-41.
23. Holland, L. N.; Shuster, L. C.; Buccafusco, J. J. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat. Neuropharmacology 32: 1387-1395; 1993.
24. Jackisch, R.; Geppert, M.; Brenner, A. S.; Illes, P. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit. Naunyn-Schmied. Arch. Pharmacol. 332: 156-162; 1986.
25. Jhamandas, K.; Sutak, M. Modification of brain acetylcholine release by morphine and its antagonists in normal and morphine-dependent rats. Br. J. Pharmacol. 50:57-62; 1974.
26. Katz, J. L.; Valentine, R. J. The opiate quasiwithdrawal syndrome in monkeys: Comparison of naloxone-precipitated withdrawal to effects of cholinergic agents. Psychopharmacology 84: 12-15; 1984.
27. Koob, G. F.; Bloom, F. E. Cellular and molecular mechanisms of drug dependence. Science 242:715-721; 1988.
28. Lapchak, P. A.; Araujo, D. M.; Collier, B. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: Hippocampus, striatum and cerebral cortex of guinea pig and rat. Neuroscience 31:313-325; 1989.
29. Mark, G.; Rada, P.; Pothos, E.; Hoebel, B. G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum and hippocampus of freely behaving rats. J. Neurochem. 58:2269-2274; 1992.
30. Meredith, G. E.; Blanf, B.; Groenewegen, H. J. The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens. Neuroscience 31:327-345; 1989.
31. Mogenson, G. J.; Jones, D. L. and Yim, C. Y. From motivation to action: Functional interface between the limbic system and the motor system. Prog. Neurobiol. 14:69-97; 1980.
32. Mulder, A. H.; Wardeh, G.; Hogenboom, F.; Frankhuyzen, A. L. Kappa and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278-280; 1984.
33. Mulder, A. H.; Wardeh, G.; Hogenboom, F.; Frankhuyzen, A. L. Selectivity of various opioid peptides towards delta, kappa, and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Neuropeptides 14:99-104; 1989.
34. Pettit, H. O.; Ettenberg, A.; Bloom, F. E.; Koob, G. F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167-173; 1984.
35. Pothos, E.; Rada, P.; Mark, G. P.; Hoebel, B. G. Microdialysis evidence that dopamine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res. 566:348-350; 1991.
36. Rada, P.; Mark, G. P.; Pothos, E.; Hoebel, B. G. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 30:1133-1136; 1991.
37. Rada, P.; Pothos, E.; Mark, G. P.; Hoebel, B. G. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res. 561:354-356; 1991.
38. Ronken, E.; Mulder, A. H.; Schoffelmeer, A. N. M. Chronic activation of mu-and kappa-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization. J. Pharmacol. Exp. Ther. 268:595-599; 1994.
39. Rothman, R. B.; Long, J. B.; Bykov, V.; Xu, H.; Jacobson, A. E.; Rice, K. C.; Holaday, J. W. Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence. Peptides 12:151-160; 1991.
40. 14C]acetylcholine from rat brain cortex slices. J. Pharm. Pharmacol. 21:546-547; 1969.
41. Smith, J. E.; Co, C.; Lane, J. D. Limbic muscarinic cholinergic and benzodiazepine receptor changes with chronic intravenous morphine and self-administration. Pharmacol. Biochem. Behav. 20:443-450; 1984.
42. Stinus, L.; Le Moal, M.; Koob, G. F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773; 1990.
43. Taguchi, K.; Hagiwara, Y.; Suzuki, Y.; Kubo, T. Effects of morphine on release of acetylcholine in the rat striatum: An in vivo microdialysis study. Naunyn-Schmied. Arch. Pharmacol. 347:9-13; 1993.
44. Tao, P. L.; Seybold, V. S.; Loh, H. H. Autoradiographic evidence for decrease in binding of mu-and delta-opioid receptors after subchronic {D-Ala, D-Leu}enkephalin treatment in rats. Eur. J. Pharmacol. 231:145-149; 1993.
45. Tempel, A.; Crain, S. M.; Peterson, E. R.; Simon, E. J.; Zukin, R. S. Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. Brain Res. 390:287-292; 1986.
46. Tempel, A.; Habas, J.; Paredes, W.; Barr, G. A. Morphine-induced downregulation of mu-opioid receptors in neonatal rat brain. Dev Brain Res. 41:129-133; 1988.
47. Valentino, R. J.; Aston-Jones, G. Activation of locus coeruleus neurons in the rat by a benzazocine derivative (UM 1046) that mimics opiate withdrawal. Neuropharmacology 22:1363-1368; 1983.
48. Van Vliet, B. J.; Dotman, C. H.; Wardeh, G.; Mulder, A. H.; Schoffelmeer, A. N. M. Differential effects of chronic agonist administration on mu-opioid receptors and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons. Life Sci. 51: 89-94; 1992.
49. Wise, R. A. Opiate reward: Sites and substrates. Neurosci. Biobehav. Rev. 13:1-29-133; 1989.
50. Wood, P. L.; Stotland, L. M. Actions of enkephalin, μ and partial agonist analgesics on acetylcholine turnover in rat brain. Neuropharmacology 19:975-982; 1980.
51. Yoburn, B. C.; Duttaroy, A.; Shah, S.; Davis, T. Opioid antagonist-induced receptor upregulation: Effects of concurrent agonist administration. Brain Res. Bull 33:237-240; 1993.
52. Zahm, D. S.; Brog, J. S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50:751-767; 1992.